Kyoto, Japan

Ryo Ota

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Kyoto University, Osaka University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryo Ota. Retrieved from https://idiyas.com/inventor/ryo-ota-eqnqsc3m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryo Ota: Innovator in Vascular Endothelial Cell Production

Introduction

Ryo Ota is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the production of vascular endothelial cells from pluripotent stem cells. His innovative methods have the potential to advance therapeutic applications in various medical fields.

Latest Patents

Ryo Ota holds a patent for a method for inducing vascular endothelial cells. This method involves several key steps: first, culturing pluripotent stem cells in a culture medium containing BMP on a culture vessel coated with a first matrix to produce mesodermal progenitor cells. Next, the resulting cells are dissociated into single cells. Finally, these cells are cultured in a medium containing VEGF on a vessel coated with a second matrix, which can include laminin-411, laminin-511, Matrigel, type IV collagen, or fibronectin. This innovative approach is crucial for advancing cell therapy techniques.

Career Highlights

Throughout his career, Ryo Ota has been associated with prestigious institutions such as Kyoto University and Osaka University. His work at these universities has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in stem cell research and regenerative medicine.

Collaborations

Ryo Ota has worked alongside notable colleagues, including Tatsutoshi Nakahata and Megumu Saito. Their collaborative efforts have further enhanced the research and development of innovative methods in the field.

Conclusion

Ryo Ota's contributions to the production of vascular endothelial cells represent a significant advancement in regenerative medicine. His innovative methods and collaborations with esteemed institutions and colleagues highlight his role as a key figure in this important field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…